Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years
Clinical trial NCT02616783 · COMPLETED
Trial details
- NCT number
- NCT02616783
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-22
- Primary completion
- 2018-02-21
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.